317 related articles for article (PubMed ID: 3935667)
1. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.
Carvalho EM; Badaró R; Reed SG; Jones TC; Johnson WD
J Clin Invest; 1985 Dec; 76(6):2066-9. PubMed ID: 3935667
[TBL] [Abstract][Full Text] [Related]
2. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
[TBL] [Abstract][Full Text] [Related]
3. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
[TBL] [Abstract][Full Text] [Related]
4. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.
Kemp M; Kurtzhals JA; Bendtzen K; Poulsen LK; Hansen MB; Koech DK; Kharazmi A; Theander TG
Infect Immun; 1993 Mar; 61(3):1069-73. PubMed ID: 8432588
[TBL] [Abstract][Full Text] [Related]
5. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis.
Carvalho EM; Bacellar O; Brownell C; Regis T; Coffman RL; Reed SG
J Immunol; 1994 Jun; 152(12):5949-56. PubMed ID: 8207220
[TBL] [Abstract][Full Text] [Related]
6. Gamma interferon production by lymphocytes from children infected with L. chagasi.
Bacellar O; Barral-Netto M; Badaró R; Carvalho EM
Braz J Med Biol Res; 1991; 24(8):791-5. PubMed ID: 1797267
[TBL] [Abstract][Full Text] [Related]
7. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
[TBL] [Abstract][Full Text] [Related]
8. Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
Khalil EA; Ayed NB; Musa AM; Ibrahim ME; Mukhtar MM; Zijlstra EE; Elhassan IM; Smith PG; Kieny PM; Ghalib HW; Zicker F; Modabber F; Elhassan AM
Clin Exp Immunol; 2005 May; 140(2):349-53. PubMed ID: 15807861
[TBL] [Abstract][Full Text] [Related]
9. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.
Kaye PM; Curry AJ; Blackwell JM
J Immunol; 1991 Apr; 146(8):2763-70. PubMed ID: 1901883
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma and interleukin-4 production by human T cells recognizing Leishmania donovani antigens separated by SDS-PAGE.
Bahrenscheer J; Kemp M; Kurtzhals JA; Gachihi GS; Kharazmi A; Theander TG
APMIS; 1995 Feb; 103(2):131-9. PubMed ID: 7748537
[TBL] [Abstract][Full Text] [Related]
11. IL-12 enhances Th1-type responses in human Leishmania donovani infections.
Ghalib HW; Whittle JA; Kubin M; Hashim FA; el-Hassan AM; Grabstein KH; Trinchieri G; Reed SG
J Immunol; 1995 May; 154(9):4623-9. PubMed ID: 7722314
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
Wolday D; Berhe N; Britton S; Akuffo H
AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
[TBL] [Abstract][Full Text] [Related]
13. In vitro responses to Leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease.
Reed SG; Carvalho EM; Sherbert CH; Sampaio DP; Russo DM; Bacelar O; Pihl DL; Scott JM; Barral A; Grabstein KH
J Clin Invest; 1990 Mar; 85(3):690-6. PubMed ID: 2107208
[TBL] [Abstract][Full Text] [Related]
14. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.
Murray HW; Stern JJ; Welte K; Rubin BY; Carriero SM; Nathan CF
J Immunol; 1987 Apr; 138(7):2290-7. PubMed ID: 3104456
[TBL] [Abstract][Full Text] [Related]
15. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.
Kurtzhals JA; Hey AS; Jardim A; Kemp M; Schaefer KU; Odera EO; Christensen CB; Githure JI; Olafson RW; Theander TG
Clin Exp Immunol; 1994 Jun; 96(3):416-21. PubMed ID: 8004810
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.
Carvalho EM; Bacellar O; Barral A; Badaro R; Johnson WD
J Clin Invest; 1989 Mar; 83(3):860-4. PubMed ID: 2522103
[TBL] [Abstract][Full Text] [Related]
17. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
18. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
[TBL] [Abstract][Full Text] [Related]
19. Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals.
Tripathi P; Ray S; Sunder S; Dube A; Naik S
Clin Exp Immunol; 2006 Feb; 143(2):380-8. PubMed ID: 16412064
[TBL] [Abstract][Full Text] [Related]
20. T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis.
Castes M; Cabrera M; Trujillo D; Convit J
J Clin Microbiol; 1988 Jun; 26(6):1207-13. PubMed ID: 3133391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
